1-1 of 1
for the MDS-004 Lenalidomide del5q Study Group
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Clinical Trials & Observations
Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Ghulam Mufti, Moshe Mittelman, Petra Muus, Peter te Boekhorst, Guillermo Sanz, Consuelo del Cañizo, Agnes Guerci-Bresler, Lars Nilsson, Uwe Platzbecker, Michael Lübbert, Bruno Quesnel, Mario Cazzola, Arnold Ganser, David Bowen, Brigitte Schlegelberger, Carlo Aul, Robert Knight, John Francis, Tommy Fu, Eva Hellström-Lindberg, for the MDS-004 Lenalidomide del5q Study Group
Journal: Blood
Blood (2011) 118 (14): 3765–3776.
https://doi.org/10.1182/blood-2011-01-330126
Published: 2011
Includes: Supplemental data